U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07522242) titled 'Safety and Efficacy of T10430 Eye Drops in Controlling Paediatric Myopia Progression' on March 25.
Brief Summary: Axial myopia is a type of nearsightedness that happens when the eye is too long from front to back. This causes distant vision to be blurry. Axial myopia tends to start during childhood and worsens over time (as the eyes continue to grow longer). This can lead to serious eye-related conditions later in life. The aim of T10430 treatment is to stop or slow this progression during childhood and therefore, prevent more serious complications. Animal studies using drugs with a similar mechanism of action as T10430 have demons...